# VersaBank: overview VBNK · Nasdaq · CIK 1690639 · [Financials](/sectors/financials.md) · fiscal year ends Oct 31 Pages: [Overview](/companies/vbnk.md) · [Financials](/companies/vbnk/financials.md) · [Filings](/companies/vbnk/filings.md) · [Insiders](/companies/vbnk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters Not reported. ## Last five fiscal years | Line item | Unit | FY2021 (2021-10-31) | FY2022 (2022-10-31) | FY2023 (2023-10-31) | FY2024 (2024-10-31) | FY2025 (2025-10-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [65.4](/filings/0001437749-22-028604.md) | [82.4](/filings/0001437749-23-034288.md) | [109](/filings/0001437749-24-036917.md) | [112](/filings/0001437749-25-037310.md) | [125](/filings/0001437749-25-037310.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [34.2%](/filings/0001437749-22-028604.md) | [27.5%](/filings/0001437749-23-034288.md) | [38.8%](/filings/0001437749-24-036917.md) | [35.6%](/filings/0001437749-25-037310.md) | [22.8%](/filings/0001437749-25-037310.md) | | Diluted EPS | $ per share | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | [(108)](/filings/0001437749-22-028604.md) | [(33.2)](/filings/0001437749-23-034288.md) | [94.4](/filings/0001437749-24-036917.md) | [254](/filings/0001437749-25-037310.md) | [43.5](/filings/0001437749-25-037310.md) | - Revenue. XBRL Revenue: ifrs-full:Revenue. - Gross margin (gross profit / revenue). XBRL Revenue: ifrs-full:Revenue. - Operating margin (operating income / revenue). XBRL Revenue: ifrs-full:Revenue. - Net margin (net income / revenue). XBRL Net income: ifrs-full:ProfitLoss; Revenue: ifrs-full:Revenue. - Diluted EPS. XBRL not reported. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: ifrs-full:CashFlowsFromUsedInOperatingActivities; Capital expenditure: ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vbnk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $41.5m | 2,929,423 | | Reduced −42,971 | | [CIBC WORLD MARKET INC.](/funds/1421224.md) | 2026-06-30 | $26.8m | 1,151,992 | | Reduced −37,065 | | [MENDON CAPITAL ADVISORS CORP](/funds/1177043.md) | 2026-06-30 | $18.1m | 780,981 | | Reduced −164,260 | | [Pembroke Management, LTD](/funds/1063497.md) | 2026-06-30 | $17.6m | 759,870 | | Added +55,094 | | [Pembroke Management, LTD](/funds/1063497.md) | 2026-06-30 | $17.6m | 759,870 | | Added +55,094 | | [TCW GROUP INC](/funds/850401.md) | 2026-06-30 | $16.7m | 721,077 | | Added +9,800 | | [Connor, Clark & Lunn Investment Management Ltd.](/funds/1596800.md) | 2026-06-30 | $16.4m | 703,971 | | Added +170,945 | | [Curi Capital, LLC](/funds/1332905.md) | 2026-06-30 | $15.8m | 680,000 | | Reduced −125,084 | | [Pacific Ridge Capital Partners, LLC](/funds/1591546.md) | 2026-06-30 | $13.6m | 585,516 | | Reduced −4,497 | | [TD Asset Management Inc](/funds/1056053.md) | 2026-06-30 | $11.5m | 493,400 | | Added +53,200 | ## Recent filings [All 183 filings](/companies/vbnk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-15 | 07:01 ET | [6-K](/filings/0001062993-26-005358.md) | Report of a foreign private issuer, period 2026-10-15 | 0001062993-26-005358 | | 2026-10-01 | 08:31 ET | [6-K](/filings/0001062993-26-005127.md) | Report of a foreign private issuer, period 2026-10-01 | 0001062993-26-005127 | | 2026-09-22 | 09:23 ET | [6-K](/filings/0001062993-26-005044.md) | Report of a foreign private issuer, period 2026-09-22 | 0001062993-26-005044 | | 2026-09-17 | 17:24 ET | [6-K](/filings/0001062993-26-005004.md) | Report of a foreign private issuer, period 2026-09-17 | 0001062993-26-005004 | | 2026-09-17 | 08:24 ET | [6-K](/filings/0001690639-26-000056.md) | Report of a foreign private issuer, period 2026-09-17 | 0001690639-26-000056 | | 2026-09-04 | 07:02 ET | [6-K](/filings/0001062993-26-004817.md) | Report of a foreign private issuer, period 2026-09-04 | 0001062993-26-004817 | | 2026-09-03 | 07:00 ET | [6-K](/filings/0001437749-26-029554.md) | Report of a foreign private issuer, period 2026-07-31 | 0001437749-26-029554 | | 2026-09-01 | 07:02 ET | [6-K](/filings/0001062993-26-004759.md) | Report of a foreign private issuer, period 2026-09-01 | 0001062993-26-004759 | | 2026-08-26 | 08:16 ET | [6-K](/filings/0001690639-26-000054.md) | Report of a foreign private issuer, period 2026-08-26 | 0001690639-26-000054 | | 2026-08-25 | 07:02 ET | [6-K](/filings/0001690639-26-000052.md) | Report of a foreign private issuer, period 2026-08-25 | 0001690639-26-000052 | ## Latest annual report [Form 40-F for the fiscal year ended Oct 31, 2025](/filings/0001437749-25-037310.md), filed Dec 10, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1690639 - Tickers: VBNK - Exchange: Nasdaq - SIC code: 6029 Commercial Banks, NEC - State of incorporation: Z4 - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 07:04 ET. No prices; not investment advice.